Half-year report · HY
4820.TEDINET S100YVT8
Period2026-01-01 → 2026-06-30
Filed2026-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.4bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥23.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.1bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥922m | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥2.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.3bn | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.3bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.4bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.1bn | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.3bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥663m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.5bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥660m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥26.8bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥27.5bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥29.0bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.8bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥7.1bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.0bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.4bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.5bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.6bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.8bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.6bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.8bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.7bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.9bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.0bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥395m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥568m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.9bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.8bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥9.58 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.44 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.18 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥9.55 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥35.32 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥23.1 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 74.3% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.9% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 42
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥79m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥79m |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | ¥19m |
| Care Welfare IT Systems Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥411m |
| Care Welfare IT Systems Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥411m |
| Care Welfare IT Systems Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | −¥130m |
| Medicine Receipt Computer And Related Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥1.2bn |
| Medicine Receipt Computer And Related Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥1.2bn |
| Medicine Receipt Computer And Related Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | −¥254m |
| Other Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥538m |
| Other Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥470m |
| Other Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥68m |
| Other Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥11m |
| Pharmacy Receipt Computer And Related Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥8.3bn |
| Pharmacy Receipt Computer And Related Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥8.3bn |
| Pharmacy Receipt Computer And Related Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥11m |
| Pharmacy Receipt Computer And Related Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥1.3bn |
| —segment total | revenue | 2026-01-01 → 2026-06-30 | ¥10.5bn |
| —segment total | revenue external | 2026-01-01 → 2026-06-30 | ¥10.4bn |
| —segment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥79m |
| —segment total | segment profit | 2026-01-01 → 2026-06-30 | ¥902m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥68m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥68m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | ¥21m |
| Care Welfare IT Systems Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥262m |
| Care Welfare IT Systems Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥262m |
| Care Welfare IT Systems Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥169m |
| Medicine Receipt Computer And Related Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥1.5bn |
| Medicine Receipt Computer And Related Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥1.5bn |
| Medicine Receipt Computer And Related Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥80m |
| Other Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥571m |
| Other Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥512m |
| Other Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥59m |
| Other Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥23m |
| Pharmacy Receipt Computer And Related Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥9.9bn |
| Pharmacy Receipt Computer And Related Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥9.9bn |
| Pharmacy Receipt Computer And Related Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥9m |
| Pharmacy Receipt Computer And Related Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥2.1bn |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥12.2bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥12.1bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥68m |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥2.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 521
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)桜橋監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)川﨑 健一 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)立石 亮太 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1InterimDuration | 12149000000 | JPY |
| Net sales (5-year summary) | InterimDuration | 10434000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 23658000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1InterimDuration | 2400000000 | JPY |
| Ordinary income loss (5-year summary) | InterimDuration | 1279000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 4313000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1InterimDuration | 1603000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | InterimDuration | 663000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 2452000000 | JPY |
| Comprehensive income (5-year summary) | Prior1InterimDuration | 1601000000 | JPY |
| Comprehensive income (5-year summary) | InterimDuration | 1054000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 2718000000 | JPY |
| Net assets (5-year summary) | Prior1InterimInstant | 20495000000 | JPY |
| Net assets (5-year summary) | InterimInstant | 19996000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 20432000000 | JPY |
| Total assets (5-year summary) | Prior1InterimInstant | 28991000000 | JPY |
| Total assets (5-year summary) | InterimInstant | 26776000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 27506000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1InterimDuration | 23.18 | |
| Basic earnings loss per share (5-year summary) | InterimDuration | 9.58 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 35.44 | |
| Diluted earnings per share (5-year summary) | Prior1InterimDuration | 23.10 | |
| Diluted earnings per share (5-year summary) | InterimDuration | 9.55 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 35.32 | |
| Equity to asset ratio (5-year summary) | Prior1InterimInstant | 0.704 | |
| Equity to asset ratio (5-year summary) | InterimInstant | 0.743 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.739 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1InterimDuration | 1673000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | InterimDuration | 1036000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 2008000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1InterimDuration | -568000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | InterimDuration | -395000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -2222000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1InterimDuration | -2248000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | InterimDuration | -1950000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -3840000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1InterimInstant | 10681000000 | JPY |
| Cash and cash equivalents (5-year summary) | InterimInstant | 6583000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 7847000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 70514800 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 70514800 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 70514800 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 70514800 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 26009000 | |
| Shareholding ratio | InterimInstant_No1MajorShareholdersMember | 0.3755 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |